Renovis

Summary

Introduction

Renovis is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics in the areas of neurological and inflammatory diseases. Using its proprietary drug discovery capabilities in medicinal chemistry, cell biology and chemical screening libraries, the company is discovering and developing drug candidates internally as well as with strategic partners.

Scope

• Contains corporate strategy, value chain presence and SWOT Analysis
• Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
• Includes information on suppliers/ partners, shareholding structure and key employees with biographies

Highlights

Renovis, a small molecule drug discovering and developing company, has proprietary pipeline products such as P2X7 and P2X3 antagonists for pain that are in preclinical development stage. The company has collaborated with Pfizer for developing VR1 antagonist for the treatment of pain.

During 2002-2006, the company recorded all of its revenues under collaborative agreements with. Pfizer for VR1 program and AstraZeneca for NXY-059, which was suspended in 2006 on failing to meet the primary end points.

The total revenues increased from $5 million in 2003 to $10 million in 2006, primarily due to the increased upfront fees and milestone payments received from collaborative partners.

Reasons to Purchase

• Access all the important information and analysis on the company in a single report
• Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain
• Gain access to company's adjusted five year financial data along with key ratios and market capitalization

Contents

• Overview
• Catalyst
• Summary
• Company Structure
  • Company Overview And Key Facts
  • Business Description
  • History
  • Company Financials
  • Stock Market Performance
  • P&L
  • Balance Sheet
  • Cash Flow
  • Business Segment Performance
  • Products & Services
  • Pipeline Products
  • Ac Forecast Product Sales
  • Competitors And Strategic Business Relationships
  • Key Competitors
  • Key Suppliers
  • Key Clients
  • Shareholding Structure
  • Strategy
  • Company View
  • Corporate Strategy
  • Swot Analysis
  • Overview
  • Strengths
  • Weaknesses
  • Opportunities
  • Threats
  • Value Chain Analysis
  • Discovery And Product Development
  • Scorecard
  • Overview
  • Scorecard Analysis
  • Key Employees
  • List Of Key Employees
  • Key Employee Biographies
  • Financial And Operational Overview
  • Financial And Operational Overview
• Appendix
• Ask The Analyst
• Datamonitor Consulting
• Disclaimer
• Table Of Figures
  • Figure 1: Renovis - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
• Table Of Tables
  • Table 1: Renovis - Key Facts
  • Table 2: Renovis - Year-End Share Price And Market Capitalization, 2002-2006 ($)
  • Table 3: Renovis - Key Events Impacting Share Price Performance
  • Table 4: Renovis - Operating Revenue/Cost Analysis, 2002-2006 ($ Mn)
  • Table 5: Renovis - Operating Cost Ratio Analysis, 2002-2006 (% Of Total Revenues)
  • Table 6: Renovis - Balance Sheet, 2002-2006 ($ Mn)
  • Table 7: Renovis - Cash Flow, 2002-2006 ($ Mn)
  • Table 8: Renovis - Revenue Breakdown By Division, 2002-2006 ($ Mn)
  • Table 9: Renovis - In-House Pipeline Products
  • Table 10: Renovis - Collaboration Products
  • Table 11: Renovis - Forecast Sales, 2006-2010 ($ Mn)
  • Table 12: Renovis - Key Competitors
  • Table 13: Renovis - Key Suppliers
  • Table 14: Renovis - Key Clients
  • Table 15: Renovis - Key Shareholders
  • Table 16: Renovis - Swot Analysis Summary
  • Table 17: Renovis - Value Chain Analysis
  • Table 18: Renovis - Scorecard
  • Table 19: Renovis - Key Employees
  • Table 20: Renovis - Financial And Operational Overview